Success Story: No RFE Issues, NIW Approved for Iranian Postdoctoral Fellow Thanks to Our Assistance
Client’s Testimonial:
“Thank you for your support and thank you for helping me have a successful case.”
On May 7th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Post-Doctoral Fellow in the Field of Electronics Engineering (Approval Notice).
General Field: Electronics Engineering
Position at the Time of Case Filing: Post-Doctoral Fellow
Country of Origin: Iran
Country of Residence at the Time of Filing: United Kingdom
Approval Notice Date: May 7th, 2025
Processing Time: 1 year, 14 months, 15 days
Case Summary:
We’re proud to share the successful I-140 NIW approval of a post-doctoral fellow, also a Ph.D. holder in electrical engineering from Iran, whose work in electronics engineering is pioneering the development of noninvasive and low-cost wearable biomedical technologies that aim to replace conventional imaging systems, reduce healthcare costs, and improve patient safety.
The client’s proposed endeavor focuses on creating wearable circuits and devices that integrate seamlessly into healthcare workflows, supporting real-time patient monitoring, early diagnosis, and minimally invasive treatment strategies. His research aligns with U.S. priorities in public health, digital health equity, and critical and emerging technologies.
To support his petition under the National Interest Waiver (NIW) category, we highlighted:
● 13 peer-reviewed journal articles, 4 conference papers, and 1 authored book;
● 149 citations, including one paper ranked in the top 20% most cited in engineering for its publication year;
● 9 completed peer reviews for leading journals in electrical and biomedical engineering.
His contributions have been widely adopted by researchers in fields ranging from optical communications to biomedical instrumentation. His work enables enhanced functionality, energy efficiency, and diagnostic precision in wearable health devices through novel amplifier designs and circuit architectures. This technology holds promise in addressing the U.S.’s growing burden of chronic diseases while reducing patient exposure to radiation and high-cost imaging.
With a record of publication in top-tier venues, active peer recognition, and clear plans for future advancement, our client was shown to be exceptionally well-positioned to lead this critical work. His NIW petition was approved without any additional evidence
requests.
We congratulate him on this achievement and look forward to his continued impact on the future of healthcare innovation.